Project Details
Description
An Open Label Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate (GPB; RAVICTI) in Pediatric Subjects under Two Years of Age with Urea Cycle Disorders (UCDs)
Status | Finished |
---|---|
Effective start/end date | 8/25/14 → 12/31/18 |
Funding
- Hyperion Therapeutics
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.